Study of Intravenous Administration of Allogeneic Adipose Stem Cells for COVID-19

NCT04486001 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sorrento Therapeutics, Inc.

Collaborators